Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib’s Toxicities in Hepatocellular Carcinoma
Conclusions:
This study suggests a clinical benefit of EP related to improved toxicity management of sorafenib that resulted in fewer dose reductions.
Implications for Practice:
Patients treated with sorafenib may benefit from an EP. Different types of EP should be compared prospectively, focusing on patients’ quality of life.
Source: Cancer Nursing - Category: Nursing Tags: Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Education | Hepatocellular Carcinoma | Liver Cancer | Nurses | Nursing | Study | Toxicology